{
    "id": "349de484-29cd-3e15-e063-6394a90a5aa5",
    "indications": "indomethacin capsules indicated : • moderate severe rheumatoid arthritis including acute flares chronic disease • moderate severe ankylosing spondylitis • moderate severe osteoarthritis • acute painful shoulder ( bursitis and/or tendinitis ) • acute gouty arthritis",
    "contraindications": "• lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) • moderate severe rheumatoid arthritis including acute flares chronic disease ; moderate severe ankylosing spondylitis ; moderate severe osteoarthritis indomethacin capsules 25 mg two three times day ( 2.2 ) • acute painful shoulder ( bursitis and/or tendinitis ) 75 mg 150 mg daily 3 4 divided doses ( 2.3 ) • acute gouty arthritis indomethacin capsules 50 mg three times day ( 2.4 )",
    "warningsAndPrecautions": "indomethacin capsules usp , 25 mg size ' 3 ' hard gelatin capsules , opaque light green cap imprinted ' h ' opaque light green body imprinted '103 ' , containing white off-white powder . supplied follows : bottles 30 capsules ndc 31722-542-30 bottles 100 capsules ndc 31722-542-01 bottles 500 capsules ndc 31722-542-05 bottles 1000 capsules ndc 31722-542-10 indomethacin capsules usp , 50 mg size ' 1 ' hard gelatin capsules , opaque light green cap imprinted ' h ' opaque light green body imprinted '104 ' , containing white off-white powder . supplied follows : bottles 30 capsules ndc 31722-543-30 bottles 100 capsules ndc 31722-543-01 bottles 500 capsules ndc 31722-543-05 bottles 1000 capsules ndc 31722-543-10 storage store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . protect light . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "indomethacin capsules contraindicated following patients : • known hypersensitivity ( e.g . , anaphylactic serious skin ) indomethacin components product [ ( 5.7 , 5.9 ) ] • history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] • setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ]",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "INDOMETHACIN",
            "code": "XXE1CET956"
        }
    ],
    "organization": "Camber Pharmaceuticals, Inc.",
    "name": "Indomethacin",
    "effectiveTime": "20250508",
    "indications_original": "Indomethacin capsules are indicated for: \n    • Moderate to severe rheumatoid arthritis including acute flares of chronic disease \n    • Moderate to severe ankylosing spondylitis \n    • Moderate to severe osteoarthritis \n    • Acute painful shoulder (bursitis and/or tendinitis) \n    • Acute gouty arthritis",
    "contraindications_original": "• Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) • The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is indomethacin capsules 25 mg two or three times a day ( 2.2 ) • The dosage for acute painful shoulder (bursitis and/or tendinitis) is 75 mg to 150 mg daily in 3 or 4 divided doses ( 2.3 ) • The dosage for acute gouty arthritis is indomethacin capsules 50 mg three times a day ( 2.4 )",
    "warningsAndPrecautions_original": "Indomethacin capsules USP, 25 mg are size '3' hard gelatin capsules, with opaque light green cap imprinted with 'H' and opaque light green body imprinted with '103', containing white to off-white powder. They are supplied as follows:\n                  \n                  Bottles of 30 capsules                              NDC     31722-542-30 \n    Bottles of 100 capsules                            NDC     31722-542-01 \n    Bottles of 500 capsules                            NDC     31722-542-05 \n    Bottles of 1000 capsules                          NDC     31722-542-10\n \n                  \n                  \n                  Indomethacin capsules USP, 50 mg are size '1' hard gelatin capsules, with opaque light green cap imprinted with 'H' and opaque light green body imprinted with '104', containing white to off-white powder. They are supplied as follows:\n                  \n                  Bottles of 30 capsules                              NDC     31722-543-30 \n    Bottles of 100 capsules                            NDC     31722-543-01 \n    Bottles of 500 capsules                            NDC     31722-543-05 \n    Bottles of 1000 capsules                          NDC     31722-543-10\n \n                  \n                     Storage\n                       Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. \n    Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Indomethacin Capsules are contraindicated in the following patients: \n    • Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product [\n \n  see Warnings and Precautions (\n  \n   5.7,\n  \n   5.9)\n \n  ] \n    • History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [\n \n  see Warnings and Precautions (\n  \n   5.7,\n  \n   5.8)\n \n  ] \n    • In the setting of coronary artery bypass graft (CABG) surgery [\n \n  see Warnings and Precautions (\n  \n   5.1)\n \n  ]"
}